Is sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer?

International Journal of Surgical Pathology

Volumn 16, Issue 4, 2008, Pages 365-374

  Sozzani, Prisca ^a   Arisio, Riccardo ^b   Porpiglia, Mauro ^a   Benedetto, Chiara ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Sant'Anna Hospital   (Italy)

Author keywords

Breast neoplasms; Carbohydrate biosynthesis; Lewis blood group system; Neoplasm metastasis; Sialyl Lewis x; Tumor associated antigens

Indexed keywords

ESTROGEN RECEPTOR; SIALYL LEWIS X ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; FOLLOW UP; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; MITOSIS INDEX; OVERALL SURVIVAL; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OLIGOSACCHARIDES; PROGNOSIS;

EID: 52449086451     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896908324668     Document Type: Article

References (35)

1. Dennis JW, Granovsky M., Warren CE Protein glycosylation in development and disease. Bioessays. 1999 ; 21: 412-421.
2. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res. 1989 ; 52: 257-331.
3. Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol. 1996 ; 179: 358-369.
4. Springer TA Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol. 1995 ; 57: 827-872.
5. Rosen SD, Bertozzi CR The selectins and their ligands. Curr Opin Cell Biol. 1994 ; 6: 663-673.
6. Munro J., Lo SK, Corless SK, Robertson MJ, Lee NC, Barnhill RL Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am J Pathol. 1992 ; 141: 1397-1408.
7. Takada A., Ohmori K., Yoneda T., et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 1993 ; 53: 354-361.
8. Hoff SD, Irimura T., Matushita Y. Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens. Arch Surg. 1990 ; 125: 206-209.
9. Hoff SD, Matsushita Y., Ota DM Increased expression of sialyl-dimeric Lex antigen in liver metastases of human colorectal carcinoma. Cancer Res. 1986 ; 49: 6883-6888.
10. Coon JS, Weinstein RS Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinoma. Hum Pathol. 1986 ; 17: 1089-1106.
11. Summers JL, Coon JS, Ward RM, Falor WH, Miller AW 3rd, Weinstein RS Prognosis in carcinoma of the urinary bladder based upon tissue ABH and Thomsen-Friedenreich antigen status and karyotype of the initial tumor. Cancer Res. 1983 ; 43: 934-939.
12. Yamaguchi A., Ding K., Maehara M., Goi T., Nakagawara G. Expression of nm23-H1 gene and sialyl Lex antigen in breast cancer. Oncology. 1998 ; 55: 357-362.
13. Inufusa H., Kojima N., Yasutomi M., Hakomori S. Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric Le(x) (defined by Mab FH6) and LCP. Clin Exp Metastasis. 1991 ; 9: 245-257.
14. Pinho SS, Matos AJ, Lopes C., et al. Sialyl Lewisx expression in canine malignant mammary tumours: correlation with clinicopathological features and E-cadherin expression. BMC Cancer. 2007 ; 7: 124.
15. Nakagoe T., Fukushima K., Tuji T., et al. Immunohistochemical expression of ABH/Lewis related antigens in primary breast carcinomas and metastatic lymph node lesions. Cancer Detect Prev. 1998 ; 22: 499-505.
16. Narita T., Hiroomi F., Satoh Y., Watanabe T., Sakamoto J., Takagi H. Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer. Cancer. 1993 ; 71: 3044-3053.
17. Nakagoe T., Fukushima K., Itoyanagi N., et al. Expression of ABH/Lewis related antigens as prognostic factors in patients with breast cancer. J Cancer Res Clin Oncol. 2002 ; 128: 257-264.
18. Monzavi-Karbassi B., Whitehead TL, Jousheghany F., et al. Deficiency in surface expression of E-selectin ligand promotes lung colonization in a mouse model of breast cancer. Int J Cancer. 2005 ; 10: 398-408.
19. European Guidelines for Quality Assurance in Mammography Screening. 3 rd ed. Luxembourg: European Commission ; 2001.
20. Bussolati G., Gugliotta P., Volante M., Pace M., Papotti M. Retrieved endogenous biotin: a novel marker and a potential pitfall in diangostic immunohistochemistry. Histopathology. 1997 ; 31: 400-407.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1977 ; 16: 95-101.
22. Woodward WA, Strom EA, Tucker SL, et al. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage specific survival. J Clin Oncol. 2003 ; 21: 3244-3248.
23. Nakagoe T., Fukushima K., Hirota M., et al. Immunohistochemical expression of sialyl Lex antigen in relation to survival of patients with colorectal carcinoma. Cancer. 1993 ; 72: 2323-2330.
24. Amado M., Carneiro F., Seixas M., Clausen H., Sobrinho-Simoes M. Dimeric sialyl Lex expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology. 1998 ; 114: 462-470.
25. Jorgensen T., Berner A., Kaalus O., Tveter KJ, Danielsen HE, Bryne M. Up-regulation of the oligosaccharide sialyl Lex: a new prognostic parameter in metastatic prostate cancer. Cancer Res. 1995 ; 55: 1817-1819.
26. Wright LC, May GL, Gregoey P., Dyne M., Holmes KT, Williams PG Inhibition of metastatic potential by fucosidase: an NMR study identifies a cell surface metastasis markers. J Cell Biochem. 1988 ; 37: 49-59.
27. Kijima-Suda I., Miyazawa T., Itoh M., Toyoshima S., Osawa T. Possible mechanism of inhibition experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside:nucleoside conjugate. Cancer Res. 1988 ; 48: 3728-3732.
28. Hebbar M., Revillion F., Louchez MM, Fournier C., Bonneterre J., Peyrat JP Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients. Clin Cancer Res. 1999 ; 5: 1427-1433.
29. Narita T., Kawasaki-Kimura N., Matsuura N., Funahashi H., Kannagi R. Adhesion of human breast cancer cells to vascular endothelium mediated by sialyl Lewisx/Eselectin. Breast Cancer. 1996 ; 3: 19-23.
30. Newman PJ The biology of PECAM-1. J Clin Invest. 1997 ; 99: 3-8.
31. Kremmidiotis G. CD44. J Biol Regul Homeost Agents. 1999 ; 13: 234-239.
32. Kaufmann M., Heider KH, Sinn HP, von Minckwitz G., Ponta H., Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet. 1995 ; 345: 615-619.
33. Righi L., Deaglio S., Pecchioni C. Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells. Am J Pathol. 2003 ; 162: 1163-1174.
34. Sapino A., Bongiovanni M., Cassoni P. Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. J Pathol. 2001 ; 194: 254-261.
35. Jeschke U., Mylonas I., Shabani N. Expression of sialyl Lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Anticancer Res. 2005 ; 25: 1615-1622.